Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD

NCT03242772 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03242772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03242772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Terminated
Start date
December 14, 2018
Completion date
April 19, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, autism spectrum disorder